PACT (Patient Preferences in Adjuvant Colorectal Cancer Therapy) - A randomised crossover clinical trial comparing Bolus Fluorouracil/Leucovorin to Capecitabine as treatment for moderate to high risk ...

Update Il y a 4 ans
Reference: EUCTR2005-000686-19

PACT (Patient Preferences in Adjuvant Colorectal Cancer Therapy) - A randomised crossover clinical trial comparing Bolus Fluorouracil/Leucovorin to Capecitabine as treatment for moderate to high risk resected colorectal cancer

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

The primary endpoint is patient preference for one of two regimens 12 weeks after randomisation, when the patient will have experienced both regimens


Inclusion criteria

  • Moderate to high risk resected colorectal cancer

Links